Wall Street analyst estimates for Cabot Corp. (CBT): consensus price target and buy/hold/sell recommendations.
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 7 |
| Hold | 7 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 15 |
| Avg rating (−2 sell to +2 buy) | 0.40 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-02 | $1.55 | ||
| 2026-08-03 | $1.67 | $1.65 | +1.2% |
| 2026-05-05 | $1.61 | $1.47 | +9.5% |
| 2026-02-03 | $1.53 | $1.40 | +9.3% |
| 2025-11-03 | $1.70 | $1.72 | -1.2% |
| 2025-08-04 | $1.90 | $1.80 | +5.6% |
| 2025-05-05 | $1.90 | $1.86 | +2.2% |
| 2025-02-03 | $1.76 | $1.74 | +1.1% |
Valuation Ratios
| P/E Ratio | 20.73 |
| Price / Book | 2.37 |
| EV / EBITDA | 7.00 |
| Dividend Yield | 2.50% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.41B | $2.72B | $3.24B | $3.34B | $2.61B | $3.41B | $4.32B | $3.93B | $3.99B | $3.71B |
| Cost of Revenue | $1.83B | $2.06B | $2.46B | $2.65B | $2.11B | $2.61B | $3.44B | $3.09B | $3.03B | $2.77B |
| Gross Profit | $578.0M | $652.0M | $781.0M | $685.0M | $500.0M | $799.0M | $885.0M | $839.0M | $960.0M | $940.0M |
| Research & Development | $53.0M | $56.0M | $66.0M | $60.0M | $57.0M | $56.0M | $55.0M | $57.0M | $63.0M | $59.0M |
| Selling, General & Admin | $275.0M | $260.0M | $305.0M | $290.0M | $292.0M | $289.0M | $258.0M | $253.0M | $283.0M | $260.0M |
| Operating Expenses | $328.0M | $319.0M | $628.0M | $379.0M | $479.0M | $345.0M | $496.0M | $313.0M | $346.0M | $319.0M |
| Operating Income | $250.0M | $336.0M | $156.0M | $306.0M | $21.0M | $454.0M | $389.0M | $526.0M | $614.0M | $621.0M |
| EBITDA | $455.0M | $499.0M | $323.0M | $462.0M | $178.0M | $615.0M | $537.0M | $685.0M | $761.0M | $794.0M |
| Interest Expense | $54.0M | $53.0M | $54.0M | $59.0M | $53.0M | $49.0M | $56.0M | $90.0M | $81.0M | $76.0M |
| Pre-tax Income | $194.0M | $288.0M | $117.0M | $256.0M | -$30.0M | $409.0M | $345.0M | $456.0M | $535.0M | $572.0M |
| Income Tax | $34.0M | $29.0M | $193.0M | $70.0M | $191.0M | $123.0M | $102.0M | -$28.0M | $111.0M | $196.0M |
| Net Income | $149.0M | $241.0M | -$113.0M | $157.0M | -$238.0M | $250.0M | $209.0M | $445.0M | $380.0M | $331.0M |
| EPS | $2.40 | $3.89 | $-1.87 | $2.67 | $-3.96 | $4.36 | $3.65 | $7.79 | $6.79 | $6.07 |
| EPS (Diluted) | $2.36 | $3.81 | $-1.83 | $2.67 | $-3.96 | $4.34 | $3.62 | $7.73 | $6.72 | $6.02 |
| Shares Outstanding (Diluted) | 62.9 M | 62.7 M | 61.7 M | 58.8 M | 56.6 M | 56.8 M | 56.9 M | 56.5 M | 55.7 M | 54.2 M |
Price
| Price | $74.43 (closing price, October 30, 2026) |
| Market Cap | $3.8B |
| Exchange | NYSE |
| Country | US |
Related companies: MEOH · HWKN · WDFC · SSL · CE · KNF · SXT · PRM
Explore sector: Basic Materials · Chemicals - Specialty
More sections of CBT: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks